Gmt Capital Corp Ocugen, Inc. Transaction History
Gmt Capital Corp
- $1.97 Billion
- Q4 2024
A detailed history of Gmt Capital Corp transactions in Ocugen, Inc. stock. As of the latest transaction made, Gmt Capital Corp holds 2,454,958 shares of OCGN stock, worth $1.35 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
2,454,958
Previous 2,454,958
-0.0%
Holding current value
$1.35 Million
Previous $2.43 Million
19.22%
% of portfolio
0.1%
Previous 0.1%
Shares
3 transactions
Others Institutions Holding OCGN
# of Institutions
123Shares Held
68.6MCall Options Held
478KPut Options Held
253K-
Black Rock Inc. New York, NY17.9MShares$9.86 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.6MShares$9.14 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA6.59MShares$3.62 Million0.0% of portfolio
-
State Street Corp Boston, MA5.87MShares$3.23 Million0.0% of portfolio
-
Northern Trust Corp Chicago, IL2.41MShares$1.32 Million0.0% of portfolio
About Ocugen, Inc.
- Ticker OCGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 216,566,000
- Market Cap $119M
- Description
- Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...